Effect of di-isopropanolnitrosamine in European hamsters. by Reznik, G. & Mohr, U.
Br. J. Cancer (1977) 36, 479.
EFFECT OF DI-ISOPROPANOLNITROSAMINE IN
EUROPEAN HAMSTERS
G. REZNIK AND U. MOHR
From^ the Abteilungfiur Experimentelle Pathologie, Mledizinische Hochschule Hannover,
Federal Republic of Germany
Received 26 April 1977 Accepted 13 June 1977
Summary.-The carcinogenic effects of di-isopropanolnitrosamine (DIPN) were
tested in hibernating and non-hibernating European hamsters. The results obtained
were compared with those produced by the same substance in Syriangoldenhamsters
and Sprague-Dawley rats. In European hamsters, tumours were produced in the
nasal cavity, trachea, lung, liver and pancreas. The main target organs were the
anterior part of the nasal cavity and liver. Only cholangiomas and cholangiocarci-
nomas were found in the liver. Early changes in the intrahepatic bile ducts and duct
epithelium of the pancreas were seen 4 weeks after treatment was started. Fourteen
out of 144 treated hamsters developed pancreatic-duct tumours, 2 of which were
malignant. The tumorigenic response in the target organs was lower in hibernating
than in non-hibernating animals.
DI-ISOPROPANOLNITROSAMINE (DIPN)
primarily affected the pancreas, liver and
kidneys of Syrian golden hamsters. It
also induced neoplasms in the respiratory
tract, mostly in the nasal cavities and
lungs (Kruger, Pour and Althoff, 1974;
Pour et al., 1974; 1975a, b). In contrast,
DIPN treatment in rats resulted in the
development of only one pancreatic tu-
mour in 150 animals, most neoplasms
occurring in the nasal cavities, thyroid
gland, renal pelvis and liver (Mohr,
Reznik and Pour, 1977; Reznik and Mohr,
1976). This substance was therefore stu-
died in European hamsters to obtain
more information about its carcinogenic
action.
MATERIALS AND METHODS
Experiments were conducted usino both
hibernating and non-hibernating European
hamsters. Six-month-old animals (strain:
Mhh EPH) 8 groups of 12 males and
12 females were individually housed in
Makrolon cages Type III (E. Becker, GmbH,
Castrop-Rauxel, FRG). Five groups were
maintained under standard laboratory condi-
tions (room temperature, 22 + 2°C; relative
humidity, 55 ± 50o; air exchanged 20 x /h)
and received a pelleted diet (RMH-TMB;
RMH = Rat Mouse Hamster, Hope Farms,
Woerden, The Netherlands), as well as
water ad libitum. The other 3 groups were
kept under cold laboratory conditions (room
temperature, 4 ± 1°C; relative humidity,
90 ± 5 o; air exchanged 8 x/h; no light)
and received the same food as described
above. It did not prove possible to establish
an LD50 for this substance when given s.c.,
since even 10 g/kg body wt. DIPN was not
toxic. The animals were treated s.c. therefore,
with 650, 325, 162 5 or 81-25 mg/kg once
weekly for 25 weeks. The animals kept under
cold laboratory conditions received either
650 or 81 25 mg/kg once weekly for 25
weeks. After completion of this treatment,
these animals were removed from cold
laboratory conditions and subsequently main-
tained under standard laboratory conditions.
Upon spontaneous death, the animals were
examined at necropsy and all organs were
fixed in 10% buffered formalin. Six-,um
thick paraplast sections were stained with
haematoxylin and eosin, periodic-acid-Schiff,
alcian blue and Kreyberg's solution for
histological examination.G. REZNIK AND U. MOHR
RESULTS
The highest dose level (650 mg/kg)
resulted in the early death (6-11 weeks)
of both hibernating and non-hibernating
animals, although the survival times
demonstrated by the latter animals were
still significantly shorter than that for
the hibernating ones (Table I). In con-
trast, the lowest dosage level (81.25
mg/kg) resulted inthehibernating animals
dying earlier than the non-hibernators.
The females lived on average 2-5 weeks
longer than the males. With decreasing
dosage the survival time increased (Table
I).
Table II gives the tumour distribution
in all groups. The first neoplasms ap-
peared in the non-hibernating animals
of the highest dosage group after only
7 weeks of treatment, and were papil-
lomas of the upper respiratory tract.
These tumours originated from the epi-
thelium of the anterior part of the nasal
cavity (atrio-, naso-, and maxilloturbinals,
nasal septum). The first malignant tu-
mours were seen after 13 weeks of treat-
ment. These were squamous-cell car-
cinomas and were again found mostly
in the anterior part of the nasal septum,
although a few were also deteoted in
the ecto- and endoturbinals. All non-
hibernating females of the lowest dosage
group developed squamous-cell carcino-
mas of the nasal cavity. The non-
hibernating animals of the dosage groups,
325, 162-5 and 81.25 mg/kg, had re-
markably similar rates of nasal-cavity
tumours. Both sexes of the two hibernat-
ing groups developed lower incidences
of such tumours than the corresponding
non-hibernators.
A number of papillary polyps were
found in the trachea of both hibernating
and non-hibernating animals. These show-
ed no dose dependency for the non-
hibernating animals, although significantly
fewer were found in the lowest-dosage
group of hibernators than in non-hiber-
nators receiving the same dose level. Two
female non-hibernators receiving 81V25
mg/kg demonstrated squamous-cell car-
cinomas of the trachea, while the males
of this group exhibited small tumours
as early as 10 weeks after the beginning
of treatment.
Pulmonary neoplasms were seen in
only 11/144 treated animals. These showed
no dose dependency and were seen in
both hibernators and non-hibernators.
Two females developed adenocarcinomas
TABLE I.-Survival Time and Dose ofDIPN-treated* European Hamsters
Total dose Survival time
(mg/kg) (weeks)
Weekly dose , A =
Compound (mg/kg) Sex Mean s.d. Mean s.d.
Treated 650
650
650
650
325
325
162 5
162 5
81 25
81 -25
81 -25
81 25
Controlst.
(H)
(H)
(NH)
(NH)
(NH)
(NH)
(NH)
(NH)
(H)
(H)
(NH)
(NH)
(H)
(H)
(NH)
(NH)
6'
&
6'
6'
6'
Q
6'
Y3
6'
7020
6565
3770
5590
6142
7280
2990
3786
2137
1584
2405
2551
1365
1430
845
2015
2600
910
1251
1089
1194
821
439
512
H = Hibernating; NH = non-hibernating.
* LD50> 10 g/kg.
t 1 ml/kg NaCl, s.c.
10-8
10-1
5 8
8 6
18 9
22-4
18 4
23 3
26 3
19 5
29 6
31 4
52 3
51 2
51.1
50 9
2.1
2 2
1 3
3 1
8 0
2 8
7 7
6 7
14 7
10-1
5 4
6-3
2 8
1 6
1 8
1 -2
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TABLE II.-Tumour Distribution in European Hamsters after DIPN Treatment
Weekly
dose
(mg/kg)
Treated 650 (H)
650 (H)
650 (NH)
650 (NH)
325 (NH)
325 (NH)
162*5 (NH)
162*5 (NH)
81-25 (H)
81*25 (H)
81-25 (NH)
81*25 (NH)
Control (H)
(H)
(NH)
(NH)
Sex
Y
YS
Y
Animals with tumours
in nasal cavity
Al
Tumour- Naso- and Endo- and
bearing maxillo- ecto-
hamsters* turbinals turbinals
5
4
5
8
10
12
11
10
5
4
11
12
0
0
0
0
2
2 (1)
1
7
10 (4)
12 (6)
8 (2)
8 (4)
4 (4)
3 (1)
9 (8)
12 (12)
0
0
0
0
0
0
0
0
1 (1)
2 (2)
0
0
1 (1)
0
2 (2)
4 (4)
0
0
0
0
H = Hibernator; NH = non-hibernator.
* Out of initial number of 12.
No. of malignant tumours given in parenthesis.
a Adenocarcinoma of the colon.
b Carcinoma of the uterus.
(one non-hibernator and one hibernator,
both from the lowest dosage level). The
benign tumours originated mostly from
the lung parenchyma.
The liver of nearly all hamsters (with
and without hibernation) treated with
FIr - iv
650 mg/kg DIPN was small and yellowish-
brown. In addition, the surface was
uneven and exhibited in all parts of the
parenchyma nodules measuring 2-4 mm
in diameter. Histologically, these nodules
were proliferations of cholangiocellular
_U. 1 -. lvur vi u i1uie ruropean namsaer a weexs atter the start of treatment with 650 mg/kg
DIPN. On the left-hand side of the picture is a large number of mucous-producing goblet cells.
On the right are proliferating duct epithelia. H. and E. x 280.
Tra-
chea
2
0
0
0
6
5
3
3
1
1
6
5 (2)
0
0
0
0
Lung Liver
0 1
0 0
0 4
0 4
0 8 (3)
1 10 (5)
2 9 (3)
3 12 (5)
1 3 (1)
1 (1) 1 (1)
1 5 (2)
2 (1) 6 (3)
0 0
0 0
0 0
0 0
Pan-
creas
1
2 (1)
0
2
0
0
3
1
3
1
1 (1)
0
0
0
0
0
Tumours
in other
organs
0
0
0
0
0
0
0
0
la
lb
0
0
0
0
0
0
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Af 11V I epithelium and possessed a large number
w t ~~~ ~~4 sr 11. 1 Ts 1 ot goblet cells (tig. 1). Unolianglontrosis
was found in hamsters that lived for
more than 12 weeks after the beginning
of treatment. The first cholangiomas
were found 10 weeks after the start of
treatment. Histological examination re-
vealed these tumours to consist of tubules
with only loosely connecting tissue. The
epithelial cells of these tubules were
cuboid, with light cytoplasm, and had
nuclei with poorly condensed chromatin.
After 18 weeks of 325 mg/kg DIPN,
cholangiocarcinomas were observed in
3000 of the animals. Similar findings
were diagnosed for the two lower-dosage
groups after 20 weeks of treatment.
These neoplasms infiltrated the liver
veins and were histologically diagnosed
as cystic papillary cholangiocarcinomas.
They were composed mainly of cuboid
epithelial cells possessing large nuclei
with poorly condensed chromatin, al-
though more compact parts with small
tubular structures were also identified.
G. 2. Fatty necrosis in the pancreas of a 'ewer hepatic tumours were seen in
male European hamster, 5 weeks after the the hibernating than in the non-hibernat-
start of treatment with 650 mg/kg DIPN. ing animals.
H. anid E. x II10.
..~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~..I. .:.I .. ...;b... Fic;. 3. Acinar-cell atrophy and goblet-cell metaplasia in a pancreas of a female European hamster,
5 weeks after the start of treatment, with 650 mg/kg DIPN. In the lower left an islet, of Langerhans
can be seen. H. ancd E. x l10.
Fr
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FIG. 4.-Goblet-cell hyperplasia (arrows) and
periductal induration (I) in pancreas of a
female European hamster, 12 weeks after
the start of treatment with 325 mg/kg
DIPN. DL = ductal lumen. H. and E.
x 110.
Fia. 5.-Intraductal polyp in pancreas of a
male European hamster, 15 weeks after the
start of treatment with 163 mg/kg DIPN.
H. and E. x 280.
FiG. 6.-Adenocarcinoma of the pancreatic duct of a male European hamster, 20 weeks after the
start of treatment with 81 *25 mg/kg DIPN. H. and E. x 280.
32
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Fia. 7. Metastasis to the mesenterium of the adenocarcinoma shown in Fig. 6. The tumouir is
surrounded by fat tissue showing infiltration of inflammatory cells. H. an(d E. x 110.
Early pancreatic changes were found
in the high-dosage groups as soon as
5 weeks after beginning treatment; these
were of fatty necrosis and were particu-
larly prominent towards the rim of all
parts of the pancreas (Fig. 2). At the
same time, acinar-cell atrophy and goblet-
cell metaplasia could be seen in the
larger ducts (Fig. 3). In animals that
died after 1]0-15 weeks of treatment,
ductal goblet-cell hyperplasia and peri-
ductal induration were seen (Fig. 4).
Intraductal polyps were diagnosed for
8/144 treated hamsters (Fig. 5). Two
adenocarcinomas of the ductal epithelium
were found (female hibernator from 650
mg/kg and male non-hibernator from
81-25 mg/kg) after 12 and 20 weeks
respectively (Fig. 6). The tumour from
the male infiltrated the mesenterium
and showed compact nodules with poorly
differentiated cells (Fig. 7). Fourteen
hamsters in all (10%) developed pan-
creatic tumours, while 10000 had pro-
liferations and distensions of duct epi-
thelia, partly with flattened cells, partly
with cuboid epithelial cells. However,
significantly fewer instances of fatty
necrosis and acinar-cell atrophy were
seen in the hibernating than in the non-
hibernating animals. In addition to these
findings, one adenocarcinoma of the
descending colon and one of the uterus
were found. Both tumours were seen in
hibernating hamsters treated with 81 25
mg/kg.
I)1SCUSSION
Compared with the neoplastic effect
of DIPN in the Syrian golden hamster
(Pour et al., 1975a) and rat (Mohr et al.,
1977) the present study showed several
quite clear differences in both incidence
and distribution of tumours. Noticeable,
however, were the high rates of nasal-
cavity tumours seen in all 3 species,
although the Syrian golden hamster de-
veloped considerably fewer squamous-cell
carcinomas of this site than either of
the other two species. Moreover, the
first papilloma in Syrian golden hamsters
was not described until after 16 weeks
oftreatment, while the European hamster
demonstrated such tumours in the nasal
cavities after only 7 weeks. No tracheal
tumours were seen in rats after DIPN,
whereas in European and Syriani golden-
hamsters up to 5000 rates of tracheal
papillary polyps were seen. The incidence
of pulmonary neoplasms in the present
study was markedly lower thaii that for
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all dose levels in the Syrian golden hamster
(up to 855%) and in the rat (up to 72%).
A similarly high incidence of pulmonary
tumours was also observed in rats after
oral DIPN (Konishi et al., 1976a). DIPN
resulted in up to a 1000% rate of liver
neoplasms in the Syrian golden hamster;
histologically these were angiosarcomas,
hepatocellular adenomas and cholangio-
carcinomas. In rats (Mohr et al., 1977)
and guinea-pigs (Rao and Reddy, 1977)
most of the liver neoplasms induced were
angiosarcomas, mixed-cell carcinomas and
hepatocellular adenomas. In contrast to
the present findings with the European
hamster and earlier results with the
Syrian golden hamster (Pour et al., 1975a),
no cholangiomas or cholangiocarcinomas
were found in the rat, and only a few in
the guinea-pig. European hamsters with
areas of proliferation of the bile-duct
epithelium also exhibited early pancreatic
changes: pancreatic duct distension and
proliferation, as well as acinar-cell atrophy,
fatty degeneration and necrosis. However,
the latter three changes appeared less
often in hibernating than in non-hibernat-
ing animals. Both the bile-duct and
pancreatic-duct epithelia showed large
numbers of goblet cells, indicating a
pronounced toxicity of DJPN on liver
and pancreas. As in the rat (Mohr et al.,
1977) and the Syrian golden hamster
(Pour et al., I 975a), single applications
of DIPN exert no toxic effects in the
European hamster. Therefore, differences
in tumour incidence of these species
cannot be related to differences in the
metabolic rate of the compound. How-
eveL, since multiple applications of DIPN
resulted in a pronounced toxicity in the
European hamster, some of its meta-
bolites would seem to accum-ulate in
this species. As with other hepatotropic
carcinogens (Bannasch, 1975), DIPN simi-
larly resulted in the early development
of cholangiofibrotic parts, with storage
of mucoid substances. Investigations with
DIPN in Syrian golden hamsters (Pour
et al., 1975a), nitrosomethylurea in guinea-
pigs (Reddy and Rao, 1975), or 4-hydroxy-
aminoquinoline-1-oxide in rats (Hayashi
and Hasegawa, 1971; Konishi et al.,
1976b) also showed a necrotizing effect
upon pancreatic acini similar to that
seen in the present study. Ethionine in
rats (Fitzgerald et al., 1968) and mice
(Lombardi, 1976) also produced such
results.
The present investigations with Euro-
pean hamsters have shown that this
animal is more sensitive to the acute
toxic effects of DIPN than the Syrian
golden hamster or rat. The early changes
in the liver and pancreas led to the early
death of the animals. This indicates that
further investigations with DIPN are
needed to find a dosage or treatment
scheme that exerts a less toxic effect on
such organs, and thus could result in
higher tumour incidences. The fact that
only one liver tumour was found in the
hibernating animals of the highest-dose
group would suggest that hibernation
alters the neoplastic influence of this
substance. Some such influence ofhiberna-
tion would also be suggested by the
decrease in toxic pancreatic alterations
(fatty necrosis, acinar-cell atrophy) seen
for hibernating animals. A reduction in
the metabolism of DIPN during hiberna-
tion could account for this phenomenon.
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